According to #TechSci Research Report- United States cardiology surgical and interventional devices market is expected to witness healthy CAGR during the forecast period. Report URL- https://www.techsciresearch.com/report/united-states-cardiology-surgical-and-interventional-devices-market/5116.html

1. MARKET INTELLIGENCE . CONSULTING
www.techsciresearch.com
UNITED STATES CARDIOLOGY SURGICAL AND INTERVENTIONAL DEVICES MARKET
2015 – 2025
FORECAST & OPPORTUNITIES

2. 2
Scope of Report
Product of Interest (POI): Cardiology Surgical and Interventional Devices
Review Period
2015 – 2018
Base Year
2019
Estimated Year
2020
Forecast Period
2021 – 2025
Year Range
REGION
• South-Region
• West-Region
• Mid-West-Region
• Northeast-Region
Cardiology surgical and interventional devices are equipments used in cardiac surgery and
generally include beating heart surgery system, cardiac ablation devices, cardiopulmonary
bypass equipment, perfusion disposables, artereotomy closure devices, cardiac catheters,
coronary guidewires, coronary stents, intravascular ultrasound systems.
Market Segmentation
END USER
• Hospitals & Clinics
• Ambulatory Surgical
Centers
• Others
• Cardiovascular
Surgical Devices
• Interventional
Devices
PRODUCT TYPE
SURGICAL
APPROACH
• Open-Heart
Surgery
• Off-Pump Heart
Surgery
• Minimally
Invasive Heart
Surgery
• Coronary Artery Bypass
Grafting (CABG)
• Transmyocardial Laser
Revascularization
(TMR)
• Heart Valve Repair or
Replacement
• Heart Transplant
• Arrhythmia Treatment
• Others
TYPE OF CARDIAC
SURGERY

3. 3
Table of Content
S. No. Contents Page No.
1. Product Overview (Definition of product and major terminologies used in the report)
2.
Research Methodology (Detailed description of the methodology used to conduct the research, Raw data
backup, list of all secondary sources, List of respondents for primary surveys)
3. Impact of COVID-19 on United States Cardiology Surgical and Interventional Devices Market
4. Executive Summary
5. Voice of Customer
6. United States Cardiology Surgical and Interventional Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1.
By Product Type (Cardiovascular Surgical Devices (Beating Heart Surgery System, Cardiac
Ablation Devices, Cardiopulmonary Bypass Equipment, Perfusion Disposables, Others),
Interventional Devices (Artereotomy Closure Devices, Cardiac Catheters, Coronary
Guidewires, Coronary Stents, Intravascular Ultrasound Systems))
6.2.2. By Surgical Approach (Open-Heart Surgery, Off-Pump Heart Surgery, Minimally Invasive Heart Surgery)
6.2.3.
By Type of Cardiac Surgery (Coronary Artery Bypass Grafting (CABG), Transmyocardial
Laser Revascularization (TMR), Heart Valve Repair or Replacement, Heart Transplant,
Arrhythmia Treatment, Others)
6.2.4. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
6.2.5. By Region
6.2.6. By Company
6.3. Product Market Map
7. United States Cardiovascular Surgical Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Type

4. 4
Table of Content
S. No. Contents Page No.
7.2.2. By Surgical Approach
7.2.3. By Type of Cardiac Surgery
7.2.4. By End User
8. United States Interventional Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Surgical Approach
8.2.3. By Type of Cardiac Surgery
8.2.4. By End User
9. Market Dynamics (This chapter assesses the major demand drivers and restraints.)
9.1. Drivers
9.2. Challenges
10. Market Trends & Developments
11. Policy & Regulatory Landscape
12. Import Export Analysis
13. United States Economic Profile
14. Competitive Landscape
14.1. Competition Outlook
14.2.
Company Profiles (Company Details, Financials (As reported), Key Market Focus, Planned
Investments, Pricing of Target Products, Market Positioning, etc)
14.2.1. Company Details
14.2.2. Products & Services
14.2.3. Financials (As Reported)

5. 5
Table of Content
S. No. Contents Page No.
14.2.4. Key Market Focus & Geographical Presence
14.2.5. Recent Developments
14.2.6. Key Management Personnel
15. Strategic Recommendations
16. About Us & Disclaimer

6. RESEARCH
METHODOLOGY

7. 7
Research Methodology
 Identifying Key Opinion
Leaders
 Questionnaire Design
 In-depth Interviews
Data
Collection
Developing List
of Respondents
Formulating
Questionnaire
Market
Profiling
Data
Validation
Data
Analysis
In-depth secondary
research was conducted to
determine top players in
the United States
Cardiology Surgical and
Interventional Devices
market, overall market size
and segmental market size.
In order to conduct
industry experts’
interviews, TechSci
formulated a detailed
discussion guide.
List of industry
players and industry
specialists was
developed.
TechSci conducted
interviews with
industry experts and
industry players for
data collection and
verification.
Data obtained as a
result of primary
and secondary
research was
validated through
rigorous
triangulation.
The data was scrutinized
using MS-Excel, statistical
tools and internal
proprietary database to
obtain qualitative and
quantitative insights about
the United States
Cardiology Surgical and
Interventional Devices
market.
Data
Collection
Data Filter
& Analysis
Research &
Intelligence
Actionable
Insights
Business
Solution
Primary Research Desk Research Company Analysis
 Recent Developments
 Market Changing
Aspects/Dynamics
 Government Policies
 Conclusion
 Market Participants
 Key Strengths
 LinkedIn
 TechSci Internal
Database
 Factiva
 Hoovers
Paid Sources
 Company Websites
 Company Annual
Reports
 White Paper Study
 Financial Reports
 Investor
Presentations
 Regulatory Body
 Associations, etc.
Secondary
Research
Primary Research

8. 8
Research Methodology
Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of United States cardiology surgical and
outlook of various segments of this market, while considering the major influencing factors such as continuous technological
devices. The study includes market forecasting, which would enable our clients to take better decisions while planning their strategy to
surgical and interventional devices market.
Methodology Followed for Calculation of Market Size:
• Market Size By Value: Market size, in terms of value, for the year 2019 was calculated based on information collected through
exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as cardiology surgical and
partners, market influencers & end users, industry experts, and other industry participants.
• The team interviewed more than 15 – 20 cardiology surgical and interventional devices companies, 45 – 50 channel partners, 80 –
other value chain stakeholders in United States Cardiology surgical and interventional devices market to obtain the overall market
Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data

9. 9
Research Methodology
• Respondents were asked about the current and future market growth rates, market shares by product type, by surgical approach, by type of cardiac surgery, by end user, by
company. Removing the outlier responses, the geometric mean of growth estimates and supplier wise revenue shares generated across various segments were considered, to arrive
at the final revenue shares. Revenue shares generated across various segments were further triangulated from other stakeholders.
Methodology Followed for Calculation of Market Shares:
• Market shares by product type, by surgical approach, by type of cardiac surgery, by end user, by region, by company were calculated based on the responses received through
primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from various segments of Cardiology Surgical and
Interventional Devices market. The final shares were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers.
Methodology Followed for Forecasting:
• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software.
• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast United States Cardiology Surgical and Interventional
Devices market, TechSci Research used various forecast techniques such as:
 Moving Average
 Time Series Analysis
 Regression Analysis
 Econometric and Judgmental Analysis

10. 10
Research Methodology
TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during short,
medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market including market
share data.
Partial List of Companies Interviewed Key Secondary Sources
 Biosense Webster, Inc.
 Boston Scientific Corporation
 C.R. Bard, Inc.
 Edwards Lifesciences Corp.
 Medtronic. Inc.
 Cardinal Health Inc.
 Abbott Laboratories Inc.
 Terumo Medical Corporation
 Becton Dickinson and Company
 Cook Medical Inc.
 World Bank
 TechSci Research Proprietary Database & Knowledge Repository
 Company Annual Reports
 Industry Magazines
 Industry Reports
 News Dailies
 Credible Paid Databases

11. 11
Industry Brief
According to TechSci Research report, “United States Cardiology Surgical and Interventional Devices Market By Product Type (Cardiovascular
Surgical Devices, Interventional Devices), By Surgical Approach (Open-Heart Surgery, Off-Pump Heart Surgery, Minimally Invasive Heart
Surgery), By Type of Cardiac Surgery (Coronary Artery Bypass Grafting (CABG), Transmyocardial Laser Revascularization (TMR), Heart Valve
Repair or Replacement, Heart Transplant, Arrhythmia Treatment, Others), By End User (Hospitals & Clinics, Ambulatory Surgical Centers,
Others), By Region, Forecast & Opportunities, 2025”, the market is anticipated to grow at a significant CAGR during the forecast period owing to
increasing prevalence of cardiovascular diseases and advancements in healthcare technologies, which has led to launch of effective, advanced
and easy-to-use cardiology surgical and interventional cardiology devices in the country. Moreover, rising emphasis on effective, accurate, and
early treatment of target diseases is augmenting the growth of United States cardiology surgical and interventional devices market. In addition to
this, increasing awareness among patients and high healthcare expenditure is expected to drive the market growth through 2025.
Furthermore, incessant technological advancements in surgical and interventional cardiology devices is acting as a growth driver for this market.
The introduction of bioabsorble stents and new generation celect platinum IVC (inferior vena cava) filter is further creating lucrative growth
opportunity for United States surgical and interventional cardiology devices market. Also, growing geriatric population and increasing cases of
coronary artery diseases in the country are fueling the growth of surgical and interventional cardiology devices market. However, stringent
regulatory guidelines and high cost of surgical and intervention cardiology procedures might hamper the market growth.
United States cardiology surgical and interventional devices market is segmented based on product type, surgical approach, type of cardiac
surgery, end user and region. Based on product type, the market is segmented into cardiovascular surgical devices and interventional devices.
The cardiovascular surgical devices segment is further categorized into beating heart surgery system, cardiac ablation devices, cardiopulmonary
bypass equipment, perfusion disposables and others. Also, the interventional devices segment can be split into artereotomy closure devices,
cardiac catheters, coronary guidewires, coronary stents and intravascular ultrasound systems. Among them, the interventional devices are
expected to register high growth during the forecast period owing to increasing uses of stents during cardiac surgeries.
Major players operating in the United States cardiology surgical and interventional devices market include Biosense Webster, Inc., Boston
Scientific Corporation, C.R. Bard, Inc., Edwards Lifesciences Corp., Medtronic. Inc., Cardinal Health Inc., Abbott Laboratories Inc., Terumo
Medical Corporation, Becton Dickinson and Company and Johnson & Johnson. Key market players are focusing on launching novel products
and are undergoing mergers & collaboration to strengthen their market position.
“The presence of leading companies and availability of advanced healthcare infrastructure is making United States a leading market for
cardiology surgical and interventional devices. Moreover, rapidly growing aging population has led to rise in cardiology surgeries in the country.
This is further expected to support the demand for cardiology surgical and interventional devices such as stents and cardiopulmonary bypass
equipment,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based United States management consulting firm.

12. 12
Sample Data - Snapshot
United States Cardiology Surgical and Interventional Devices Market Size, By Value (USD Million) & By Volume (Thousand Units), 2015–
2025F
CAGR By Value & Volume
XX%
CAGR By Value & Volume
YY%
5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00
10.00 20.00 30.00 40.00 50.00 60.00 70.00 80.00 90.00 100.00 110.00
2015 2019 2020E 2025F
By Value (USD Million)
By Volume (Thousand Units)
United States Cardiovascular Surgical Devices Market Share, By Type, By Value, 2015–2025F
35%
35%
35%
35%
35%
35%
35%
35%
35%
35%
35%
40%
40%
40%
40%
40%
40%
40%
40%
40%
40%
40%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
2015
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
Cardiac Ablation Devices Cardiopulmonary Bypass Equipment Perfusion Disposables
United States Cardiovascular Surgical Devices Market Share, By Surgical Approach, By Value, 2015–2025F
35%
35%
35%
35%
35%
35%
35%
35%
35%
35%
35%
40%
40%
40%
40%
40%
40%
40%
40%
40%
40%
40%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
2015
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
Open-Heart Surgery Off-Pump Heart Surgery Minimally Invasive Heart Surgery

13. 13
Report Ordering
License Type Price
Electronic Access - Single User License $3450
Electronic Access - Multi-User License $4450
Custom Research License $8450
Report Price
To View Sample OR Purchase Report
Report Name: UNITED STATES CARDIOLOGY SURGICAL AND INTERVENTIONAL DEVICES MARKET
FORECAST & OPPORTUNITIES
2015 – 2025

14. About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in
number of areas to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality
analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and global
company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.
Related Reports
• India Carbamazepine Market By Route of Administration (Oral v/s Intravenous), By Source (In-house v/s Contract Manufacturing Organizations),
By Form (Tablet, Capsule, Injection, Syrup, Others), By Distribution Channel (Online v/s Offline), By Application (Epilepsy, Neuropathic Pain,
Seizure, Bipolar Disorder, Trigeminal Neuralgia, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities,
FY2025
• India Cefixime Market By Route of Administration (Oral v/s Intravenous), By Dose (100 mg, 200 mg, 500 mg, Others), By Source (In-house v/s
Contract Manufacturing Organizations), By Form (Tablet, Capsule, Powder, Injection, Others), By Distribution Channel (Online v/s Offline), By
Application (Urinary tract infections, Otitis media, Pharyngitis and tonsillitis, Others), By End User (Adult v/s Children), By Company, By Region,
Forecast & Opportunities, FY2025
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely,
accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it
considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible
for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the
subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this
document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior
approval of TechSci Research.
TechSci Research – North America
708 Third Avenue, Manhattan,
New York, United States
Tel: +1- 646- 360- 1656
Email: sales@techsciresearch.com
www.techsciresearch.com
Disclaimer
TechSci Research – Europe
54, Old brook, Bretton,
Peterborough,
United Kingdom
Email: sales@techsciresearch.com
www.techsciresearch.com
TechSci Research – Asia-Pacific
B – 44, Sector – 57, Noida, National Capital
Region, U.P. - India
Tel: +91-120-4523900
Email: sales@techsciresearch.com
www.techsciresearch.com